Current filters:  
Canada
Healthcare
Healthcare
Canada
Gardiner Roberts LLP
As legal counsel for pharmacists, we are often asked questions about what happens when a pharmacist is referred to the Discipline Committee of the Ontario College of Pharmacists (the "OCP").
Fasken
On January 26, Health Canada issued a notice clarifying how a drug's "dormant" status on the drug product database may affect whether that drug...
Miller Thomson LLP
On February 13, 2024, Ontario's Divisional Court released its decision in Spirou v. College of Physiotherapists of Ontario ("Spirou"), with the Court confirming that the College...
Hicks Morley Hamilton Stewart Storie LLP
Bill 166, Strengthening Accountability and Student Supports Act, 2024 (Bill 166) was tabled by the Ontario Minister of Colleges and Universities (Minister) on February 26, 2024.
Carters Professional Corporation
The new Qualifying Disbursement Regime has become a viable option for registered charities to consider when working with non-qualified donees in achieving...
Carters Professional Corporation
A new T3 Trust Income Tax and Information Return ("T3") was released by the Canada Revenue Agency (CRA) in December 2023.
McCarthy Tétrault LLP
Earlier this month, the NDP and the Liberals announced a deal to introduce the first piece of a national pharmacare program providing federal funding for medications for Canadians.
Clark Wilson LLP
Exciting news for hopeful parents-to-be in British Columbia! The recent announcement in the B.C. Budget 2024-2025 reveals that the province will now
Gardiner Roberts LLP
As legal counsel for chiropractors, we are often asked questions about what happens when a chiropractor is referred to the Discipline Committee of the College of Chiropractors of Ontario (the "CCO").
Osler, Hoskin & Harcourt LLP
Legislation for the period 02/08 to 02/21
Smart & Biggar
We previously reported Health Canada's March 27, 2023 consultation on its proposed application of the definition of Canadian reference product (CRP) based on "Dormant Status" under s. C.08.001.1(b)...
Carters Professional Corporation
For a more detailed commentary see the Charity & NFP Law Bulletin No. 524 Information is current as of February 9th, 2024, but subject to change...
Smart & Biggar
On February 7, 2024, the Federal Court dismissed Takeda's action under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations in relation to dexlansoprazole.
Gowling WLG
On May 12, 2023, Health Canada published a cost recovery proposal for natural health products (NHPs). The dietary supplement industry's response has been overwhelmingly critical of the proposal for a variety of reasons.
Smart & Biggar
On May 26, 2023, the Minister of Health determined that Biosimilar Collaborations Ireland Limited was entitled to the benefit of section 5 of the Patented Medicines (Notice of Compliance) Regulations (Regulations)...
Gardiner Roberts LLP
In my opinion, here are the top 10 items that Health Professionals need to know about Discipline Committee hearings...
Cassels
The Patented Medicine Prices Review Board Canada (PMPRB) published its "What We Learned Report" (Report) on February 15, 2024...
McCague Borlack LLP
In Cox v. Miller (Cox), the British Columbia Court of Appeal (the "BCCA") upheld the trial judge's decision by affirming that irrespective of an individual's...
McLeish Orlando LLP
Justice Koehnen provides a helpful avenue to get ahead of the current 14- to 20-month wait for motions via case conferences. While the Respondents submitted...
Bennett Jones LLP
Our Field Notes series is intended to provide a high-level overview of the emerging issues in the landscape of pesticides in Canada...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media